1
|
Davi G and Patrono C: Platelet activation
and atherothrombosis. N Engl J Med. 357:2482–2494. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Stegner D and Nieswandt B: Platelet
receptor signaling in thrombus formation. J Mol Med (Berl).
89:109–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kahner BN, Shankar H, Murugappan S, Prasad
GL and Kunapuli SP: Nucleotide receptor signaling in platelets. J
Thromb Haemost. 4:2317–2326. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Li Z, Delaney MK, O’Brien KA and Du X:
Signaling during platelet adhesion and activation. Arterioscler
Thromb Vasc Biol. 30:2341–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Vanhoutte PM: COX-1 and vascular disease.
Clin Pharmacol Ther. 86:212–215. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Nakahata N: Thromboxane A2:
physiology/pathophysiology, cellular signal transduction and
pharmacology. Pharmacol Ther. 118:18–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Enomoto Y, Adachi S, Matsushima-Nishiwaki
R, Doi T, Niwa M, Akamatsu S, Tokuda H, Ogura S, Yoshimura S, Iwama
T and Kozawa O: Thromboxane A(2) promotes soluble CD40 ligand
release from human platelets. Atherosclerosis. 209:415–421. 2010.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Takai Y, Sasaki T and Matozaki T: Small
GTP-binding proteins. Physiol Rev. 81:153–208. 2001.PubMed/NCBI
|
9
|
Pleines I, Elvers M, Strehl A, Pozgajova
M, Vargo-Szabo D, May F, Chrostek-Grashoff A, Brakebusch C and
Nieswandt B: Rac1 is essential for phospholipase C-gamma2
activation in platelets. Pflugers Arch. 457:1173–1185. 2009.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Soulet C, Gendreau S, Missy K, Benard V,
Plantavid M and Payrastre B: Characterisation of Rac activation in
thrombin-and collagen-stimulated human blood platelets. FEBS Lett.
507:253–258. 2001. View Article : Google Scholar : PubMed/NCBI
|
11
|
Tohgi H, Takahashi H, Watanabe K, Kuki H
and Shirasawa Y: Development of large platelet aggregates from
small aggregates as determined by laser-light scattering: effects
of aggregant concentration and antiplatelet medication. Thromb
Haemost. 75:838–843. 1996.
|
12
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and alphaB-crystallin by cyclic AMP in C6 rat glioma cells. J
Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
13
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Bertelé V, Di Minno G and de Gaetano G:
U-46619, a stable analogue of prostaglandin H2, induces retraction
of human platelet-rich plasma clots. Thromb Res. 18:543–545.
1980.PubMed/NCBI
|
15
|
Gao Y, Dickerson JB, Guo F, Zheng J and
Zheng Y: Rational design and characterization of a Rac
GTPase-specific small molecule inihitor. Proc Natl Acad Sci USA.
101:7618–7623. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Rendu F and Brohard-Bohn B: The platelet
release reaction: granules’ constituents, secretion and functions.
Platelets. 12:261–273. 2001.
|
17
|
Heldin CH and Westermark B: Mechanism of
action and in vivo role of platelet-derived growth factor. Physiol
Rev. 79:1283–1316. 1999.PubMed/NCBI
|
18
|
Hermann A, Rauch BH, Braun M, Schrör K and
Weber AA: Platelet CD40 ligand (CD40L) - subcellular localization,
regulation of expression, and inhibition by clopidogrel. Platelets.
12:74–82. 2001. View Article : Google Scholar : PubMed/NCBI
|
19
|
André P, Nannizzi-Alaimo L, Prasad SK and
Phillips DR: Platelet-derived CD40L: the switch-hitting player of
cardiovascular disease. Circulation. 106:896–899. 2002.PubMed/NCBI
|
20
|
Henn V, Slupsky JR, Gräfe M,
Anagnostopoulos I, Förster R, Müller-Berghaus G and Kroczek RA:
CD40 ligand on activated platelets triggers an inflammatory
reaction of endothelial cells. Nature. 391:591–594. 1998.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Heeschen C, Dimmeler S, Hamm CW, van den
Brand MJ, Boersma E, Zeiher AM and Simoons ML; CAPTURE Study
Investigators. Soluble CD40 ligand in acute coronary syndromes. N
Engl J Med. 348:1104–1111. 2003. View Article : Google Scholar : PubMed/NCBI
|